Psychemedics (PMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,861 | -4,154 | -1,084 | -665 | -3,859 |
| Depreciation Amortization | 2,081 | 2,670 | 3,316 | 3,690 | 3,626 |
| Income taxes - deferred | N/A | 691 | -531 | -371 | -339 |
| Accounts receivable | 1,187 | 52 | 377 | -760 | 424 |
| Accounts payable and accrued liabilities | -290 | 304 | -546 | 417 | -281 |
| Other Working Capital | -205 | -1,726 | 2,317 | -802 | -4,168 |
| Other Operating Activity | 17 | 683 | 1,041 | -1,095 | 514 |
| Operating Cash Flow | $929 | $-1,480 | $4,890 | $414 | $-4,083 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -87 | -159 | -187 | -182 | -851 |
| Other Investing Activity | 0 | 0 | -21 | -38 | -7 |
| Investing Cash Flow | $-87 | $-159 | $-208 | $-220 | $-858 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 2,181 |
| Debt Repayment | -305 | -294 | -664 | -688 | -678 |
| Common Stock Issued | 1,965 | -54 | -74 | -68 | -9 |
| Common Stock Repurchased | -2,563 | 0 | N/A | N/A | N/A |
| Dividend Paid | N/A | -799 | -1,186 | -279 | -993 |
| Other Financing Activity | -486 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-1,389 | $-1,147 | $-1,924 | $-1,035 | $501 |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | -10 |
| Beginning Cash Position | 1,964 | 4,750 | 1,992 | 2,833 | 7,283 |
| End Cash Position | 1,417 | 1,964 | 4,750 | 1,992 | 2,833 |
| Net Cash Flow | $-547 | $-2,786 | $2,758 | $-841 | $-4,450 |
| Free Cash Flow | |||||
| Operating Cash Flow | 929 | -1,480 | 4,890 | 414 | -4,083 |
| Capital Expenditure | -87 | -159 | -187 | -182 | -991 |
| Free Cash Flow | 842 | -1,639 | 4,703 | 232 | -5,074 |